Diosmetin Induces Cell Apoptosis by Regulating CYP1A1/CYP1A2 Due to p53 Activation in HepG2 Cells

By  

Protein and Peptide Letters, Vol. 24, Iss. 5, 2017-05 ,pp. : 406-412

Bentham Science Publishers

Access to resources Recommend Favorite

Diosmetin, a Potential p53 Activator, Performs Anticancer Effect by Regulating Cell Cycling and Cell Proliferation in HepG2 Cells

By  

Protein and Peptide Letters, Vol. 24, Iss. 5, 2017-05 ,pp. : 413-418

Bentham Science Publishers

Access to resources Recommend Favorite

Comparison of the Structure and Biological Activities of Wild-type and Mutant Liver-targeting Peptide Modified Recombinant Human Endostatin (rES-CSP) in Human Hepatocellular Carcinoma HepG2 Cells

By  

Protein and Peptide Letters, Vol. 22, Iss. 5, 2015-01 ,pp. : 470-479

Bentham Science Publishers

Access to resources Recommend Favorite

TGF-β and Hepatocellular Carcinoma: When A Friend Becomes An Enemy

By  

Current Protein and Peptide Science, Vol. 19, Iss. 12, 2018-12 ,pp. : 1172-1179

Bentham Science Publishers

Access to resources Recommend Favorite

Efficient Growth Inhibition of Human Osteosarcoma Cells Using a Peptide Derived from the MDM-2-Binding Site of p53

By  

Protein and Peptide Letters, Vol. 17, Iss. 5, 2010-05 ,pp. : 610-615

Bentham Science Publishers

Access to resources Recommend Favorite